DGIdb - AMPHOTERICIN B Drug Record

AMPHOTERICIN B chembl:CHEMBL267345 Approved

Alternate Names:

AMPHOTERICINE B
AMPHOTERICIN B LIPOSOMAL COMPLEX
AMPHOTERICITIN B
FUNGILIN
AMPOTERICIN B
FUNGILIN IN ORABASE
AMBISOME
AMPHOTERICIN
AMPHOTERCIN B
AMPHO-MORONAL
ABELCET
AMPHOTERICIN B LIPID COMPLEX
FUNGIZONE
AMPHOTREICIN B
AMPHOTEC
AMOPHOTERICIN B
AMPHOTERICIN B
NSC-527017
APT370
AMPHOTERICINUM B
AMPH-B
C-AMB
AMFOTERICINA B
LIPOSOMAL AMPHOTERICIN B
AMPHOTÉRICINE B
drugbank:00681
chembl:CHEMBL267345
chemidplus:1397-89-3
rxcui:732
pubchem.compound:5280965

Drug Info:

(0 More Sources)

Publications:

Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol
Peinado et al., 1992, Effect of amphotericin B on dopachrome tautomerase activity and other melanogenic parameters in cultured B16/F10 melanoma cells., Pigment Cell Res.

AMPHOTERICIN B DCT

Interaction Score: 17.67

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
1492075

Sources:
NCI
AMPHOTERICIN B TNF

Interaction Score: 0.13

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
AMPHOTERICIN B CYP2C9

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
AMPHOTERICIN B CYP1A2

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
AMPHOTERICIN B CYP2D6

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC
AMPHOTERICIN B HSD17B10

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
AMPHOTERICIN B CYP3A4

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22931300

Sources:
DTC

DTC: AMPHOTERICIN B
- Version: 02-September-2020
Alternate Names:

CHEMBL267345 ChEMBL Drug ID

Drug Info:

Publications:

Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol
NCI: FUNGIZONE
- Version: 14-September-2017
Alternate Names:

C238 NCI drug code

Drug Info:

Publications:

Peinado et al., 1992, Effect of amphotericin B on dopachrome tautomerase activity and other melanogenic parameters in cultured B16/F10 melanoma cells., Pigment Cell Res.
ChemblDrugs: chembl:CHEMBL267345
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:

AMPHOTERICIN B Drug Record

AMPHOTERICIN B chembl:CHEMBL267345 Approved

Alternate Names:

Drug Info:

Publications:

AMPHOTERICIN B DCT

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 1492075

Sources: NCI

AMPHOTERICIN B TNF

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: DTC

AMPHOTERICIN B CYP2C9

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22931300

Sources: DTC

AMPHOTERICIN B CYP1A2

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22931300

Sources: DTC

AMPHOTERICIN B CYP2D6

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22931300

Sources: DTC

AMPHOTERICIN B HSD17B10

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: DTC

AMPHOTERICIN B CYP3A4

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22931300

Sources: DTC

DTC: AMPHOTERICIN B

Alternate Names: CHEMBL267345 ChEMBL Drug ID

Drug Info:

Publications: Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for &gt;200 compounds., Chem Res Toxicol

NCI: FUNGIZONE

Alternate Names: C238 NCI drug code

Drug Info:

Publications: Peinado et al., 1992, Effect of amphotericin B on dopachrome tautomerase activity and other melanogenic parameters in cultured B16/F10 melanoma cells., Pigment Cell Res.

ChemblDrugs: chembl:CHEMBL267345

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality:

n/a

PMIDs:
1492075

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
22931300

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
22931300

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
22931300

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
22931300

Sources:
DTC

Alternate Names:

CHEMBL267345 ChEMBL Drug ID

Publications:

Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol

Alternate Names:

C238 NCI drug code

Publications:

Peinado et al., 1992, Effect of amphotericin B on dopachrome tautomerase activity and other melanogenic parameters in cultured B16/F10 melanoma cells., Pigment Cell Res.